Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy

Immune Network
Kyung Hwan KimEui-Cheol Shin

Abstract

Immune checkpoint blockade targeting PD-1 and PD-L1 has resulted in unprecedented clinical benefit for cancer patients. Anti-PD-1/PD-L1 therapy has become the standard treatment for diverse cancer types as monotherapy or in combination with other anti-cancer therapies, and its indications are expanding. However, many patients do not benefit from anti-PD-1/PD-L1 therapy due to primary and/or acquired resistance, which is a major obstacle to broadening the clinical applicability of anti-PD-1/PD-L1 therapy. In addition, hyperprogressive disease, an acceleration of tumor growth following anti-PD-1/PD-L1 therapy, has been proposed as a new response pattern associated with deleterious prognosis. Anti-PD-1/PD-L1 therapy can also cause a unique pattern of adverse events termed immune-related adverse events, sometimes leading to treatment discontinuation and fatal outcomes. Investigations have been carried out to predict and monitor treatment outcomes using peripheral blood as an alternative to tissue biopsy. This review summarizes recent studies utilizing peripheral blood immune cells to predict various outcomes in cancer patients treated with anti-PD-1/PD-L1 therapy.

References

Dec 22, 1998·The Journal of Experimental Medicine·A J ZajacR Ahmed
Oct 18, 2005·Current Opinion in Immunology·Ulrich Walter, Pere Santamaria
Mar 22, 2007·Nature Immunology·Estelle BettelliVijay K Kuchroo
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Dec 18, 2009·Nature Immunology·Kajsa Wing, Shimon Sakaguchi
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
May 7, 2016·Science·Christian U BlankTon N Schumacher
May 19, 2016·Immunity·Margaret K CallahanJedd D Wolchok
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi
Nov 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stéphane ChampiatCharles Ferté
Jan 7, 2017·Nature Reviews. Drug Discovery·W Joost LesterhuisRichard A Lake
Feb 12, 2017·Cell·Padmanee SharmaAntoni Ribas
Feb 18, 2017·The New England Journal of Medicine·Joaquim BellmuntUNKNOWN KEYNOTE-045 Investigators
Mar 30, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shumei KatoRazelle Kurzrock
Apr 12, 2017·Nature·Alexander C HuangE John Wherry
Apr 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Saâda-BouzidC Le Tourneau
Apr 28, 2017·Proceedings of the National Academy of Sciences of the United States of America·Alice O KamphorstSuresh S Ramalingam
May 6, 2017·Nature Medicine·Carl H JuneJeffrey A Bluestone
May 18, 2017·The New England Journal of Medicine·Khashayar Esfahani, Wilson H Miller
Oct 27, 2017·Expert Review of Molecular Diagnostics·Paul Hofman
Jan 9, 2018·The Journal of Clinical Investigation·Rituparna DasKavita M Dhodapkar
Jan 9, 2018·Nature Medicine·Carsten KriegBurkhard Becher
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann
Feb 8, 2018·Annual Review of Medicine·Masao HashimotoRafi Ahmed
Mar 16, 2018·BMJ : British Medical Journal·Shrujal BaxiDeborah Korenstein
Mar 24, 2018·Science·Antoni Ribas, Jedd D Wolchok
Jul 11, 2018·International Immunopharmacology·Kristian M HargadonCorey J Williams

❮ Previous
Next ❯

Citations

Jul 6, 2020·International Immunology·Alok Kumar, Kenji Chamoto

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
flow cytometry

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.